SCHEMBL11214362

SCHEMBL11214362

CCc1ccccc1N1CCc2cc(OC)c(OC)c(Sc3ccccc3)c2CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ USP2 O75604 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ POLB P06746 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ DRD2 P14416 2/20 0.35
▸ DRD4 P21917 2/20 0.35
▸ HRH2 P25021 2/20 0.35
▸ DRD3 P35462 2/20 0.35
▸ HRH1 P35367 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ MTNR1A P48039 1/20 0.35
▸ MTNR1B P49286 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11160967 0.83 DRD1 (0.47) LMNAPOLBTDP1DRD2DRD4
SCHEMBL11167197 0.80 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2KDM4ERAB9AMEN1
Bromide SCHEMBL11156982 0.79 DRD1 (0.36) LMNASMN1; SMN2KDM4ERAB9ADRD2
SCHEMBL11169221 0.79 MEN1 (0.39) LMNAMEN1KMT2APOLBTDP1
Fumaric Acid SCHEMBL11169294 0.78 MEN1 (0.43) LMNAALDH1A1HTTSMN1; SMN2KDM4E
Fumaric Acid SCHEMBL11169280 0.78 MEN1 (0.43) LMNAALDH1A1HTTSMN1; SMN2KDM4E
SCHEMBL11215748 0.78 CYP2D6 (0.41) MEN1KMT2APOLBHRH1HRH3
SCHEMBL11214359 0.78 KCNH2 (0.46) —
SCHEMBL11160646 0.76 GAA (0.47) ALDH1A1USP2HTTKDM4EMEN1
SCHEMBL11171000 0.74 DRD1 (0.38) LMNAALDH1A1L3MBTL1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080012-A1 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 — — EP disclosed
EP-0007070-B1 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1983-01-19 — — EP disclosed
US-4265890-A ANTIPSYCHOTIC, ANTIEMETICS SMITHKLINE CORPORATION (US) 1981-05-05 — — US disclosed
EP-0007070-A1 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity SMITHKLINE BECKMAN CORPORATION (US) 1980-01-23 — — EP disclosed
Send feedback